Plerixafor: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Plerixafor. Educational only — not medical advice.
Labeled uses
Plerixafor Injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM).
Source: FDA labeling via NIH DailyMed (set fad65f5b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.